The results indicated that the level of γc was increased in these cells after PD-1 blockade treatment (Fig. 1c), suggesting that PD-1 signaling negatively regulates γc level in tumor-infiltrating CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.